Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
Bodini M, Ronchini C, Giacò L, Russo A, Melloni GE, Luzi L, Sardella D, Volorio S, Hasan SK, Ottone T, Lavorgna S, Lo-Coco F, Candoni A, Fanin R, Toffoletti E, Iacobucci I, Martinelli G, Cignetti A, Tarella C, Bernard L, Pelicci PG, Riva L. Bodini M, et al. Among authors: cignetti a. Blood. 2015 Jan 22;125(4):600-5. doi: 10.1182/blood-2014-05-576157. Epub 2014 Dec 12. Blood. 2015. PMID: 25499761 Free PMC article. Review.
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.
Riva L, Ronchini C, Bodini M, Lo-Coco F, Lavorgna S, Ottone T, Martinelli G, Iacobucci I, Tarella C, Cignetti A, Volorio S, Bernard L, Russo A, Melloni GE, Luzi L, Alcalay M, Dellino GI, Pelicci PG. Riva L, et al. Among authors: cignetti a. Blood Cancer J. 2013 Sep 13;3(9):e147. doi: 10.1038/bcj.2013.46. Blood Cancer J. 2013. PMID: 24036946 Free PMC article. No abstract available.
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.
Riva L, Ronchini C, Bodini M, Lo-Coco F, Lavorgna S, Ottone T, Martinelli G, Iacobucci I, Tarella C, Cignetti A, Volorio S, Bernard L, Russo A, Melloni GE, Luzi L, Alcalay M, Dellino GI, Pelicci PG. Riva L, et al. Among authors: cignetti a. Blood Cancer J. 2014 Mar 21;4(3):e195. doi: 10.1038/bcj.2014.19. Blood Cancer J. 2014. PMID: 24658373 Free PMC article. No abstract available.
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program.
Guolo F, Fianchi L, Minetto P, Clavio M, Gottardi M, Galimberti S, Rizzuto G, Rondoni M, Bertani G, Dargenio M, Bilio A, Scappini B, Zappasodi P, Scattolin AM, Grimaldi F, Pietrantuono G, Musto P, Cerrano M, D'Ardia S, Audisio E, Cignetti A, Pasciolla C, Pavesi F, Candoni A, Gurreri C, Morselli M, Alati C, Fracchiolla N, Rossi G, Caizzi M, Carnevale-Schianca F, Tafuri A, Rossi G, Ferrara F, Pagano L, Lemoli RM. Guolo F, et al. Among authors: cignetti a. Blood Cancer J. 2020 Oct 6;10(10):96. doi: 10.1038/s41408-020-00361-8. Blood Cancer J. 2020. PMID: 33024084 Free PMC article. Clinical Trial.
Lymphocyte transformation and autoimmune disorders.
Tarella C, Gueli A, Ruella M, Cignetti A. Tarella C, et al. Among authors: cignetti a. Autoimmun Rev. 2013 Jun;12(8):802-13. doi: 10.1016/j.autrev.2012.11.004. Epub 2012 Dec 4. Autoimmun Rev. 2013. PMID: 23219771 Review.
Chronic myeloid leukemia stem cells.
Houshmand M, Simonetti G, Circosta P, Gaidano V, Cignetti A, Martinelli G, Saglio G, Gale RP. Houshmand M, et al. Among authors: cignetti a. Leukemia. 2019 Jul;33(7):1543-1556. doi: 10.1038/s41375-019-0490-0. Epub 2019 May 24. Leukemia. 2019. PMID: 31127148 Free PMC article. Review.
Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas.
Ramadan S, Ceparano G, Cignetti A, Sammassimo S, Bagnardi V, Pagan E, Gottardi D, Fiori S, Passerini R, Radice T, Saglio G, Tarella C. Ramadan S, et al. Among authors: cignetti a. Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021018. doi: 10.4084/MJHID.2021.018. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 33747399 Free PMC article.
Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition.
Elia AR, Circosta P, Sangiolo D, Bonini C, Gammaitoni L, Mastaglio S, Genovese P, Geuna M, Avolio F, Inghirami G, Tarella C, Cignetti A. Elia AR, et al. Among authors: cignetti a. Hum Gene Ther. 2015 Apr;26(4):220-31. doi: 10.1089/hum.2014.112. Epub 2015 Apr 13. Hum Gene Ther. 2015. PMID: 25758764
76 results